GHK-Cu Research Overview

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide–copper complex identified in human plasma, saliva, and urine. First isolated and characterized in the 1970s, it has since attracted scientific interest across multiple research domains including skin biology, wound healing, inflammation, vascular biology, and neuroscience. This article provides an educational overview of peer-reviewed GHK-Cu research for laboratory scientists and researchers.

All GHK-Cu products supplied by New Tech Science are intended exclusively for in vitro and preclinical laboratory research. Nothing in this article constitutes medical advice or implies suitability for human or veterinary use.

Molecular Structure and Copper-Binding Properties

GHK-Cu consists of three amino acids — glycine, histidine, and lysine — complexed with a copper(II) ion. Early structural studies using optical and electron paramagnetic resonance spectroscopies established that at physiological pH, GHK forms a mononuclear 1:1 complex with copper through nitrogen coordination, providing the stable solution-phase structure underlying its observed biological activity in laboratory systems [1].

Biochemical studies using potentiometric titration and equilibrium dialysis demonstrated that at equimolar concentrations, GHK competes with serum albumin to bind approximately 42% of available copper at physiological pH — leading researchers to propose that the peptide functions as a natural carrier for shuttling copper from circulation into tissues [2].

The plasma concentration of GHK-Cu has been observed to decline with age, measured at approximately 200 ng/mL in younger adults and falling significantly by the eighth decade of life. The biological significance of this decline remains an active research question.

Collagen Synthesis and Extracellular Matrix Research

GHK-Cu has been extensively studied in the context of fibroblast biology and extracellular matrix production. A 2015 review synthesized evidence that GHK stimulates production of collagen, elastin, and glycosaminoglycans while also modulating matrix metalloproteinase activity to support balanced extracellular matrix remodeling. The review attributed these broad effects to GHK’s capacity to influence expression of a large number of human genes relevant to cellular health programs, including restoration of fibroblast function in cultures following radiation damage [3].

Skin Biology: Keratinocyte and Integrin Research

Research on cultured keratinocytes has examined how GHK-Cu influences epidermal biology at the cellular level. In a 2009 in vitro study, copper-GHK treatment increased keratinocyte proliferation and significantly upregulated integrin alpha6 and beta1 expression — proteins essential for cell-matrix adhesion and epidermal structural integrity — while also elevating p63, a transcription factor associated with basal stem cell identity [4].

A 2012 study confirmed that copper-free GHK produced comparable effects on basal stem cell markers, increasing PCNA and p63 expression and promoting a stem-cell-like morphology in both 2D keratinocyte cultures and 3D skin tissue models. The findings contribute to the body of in vitro evidence on GHK-Cu effects on keratinocyte biology [5].

Wound Healing and Tissue Repair

Wound healing applications of GHK-Cu have been explored in combination biomaterial systems. A 2023 study developed a blue-light-activated hyaluronic acid hydrogel scaffold incorporating self-assembling GHK-Cu peptide nanofibers. The system demonstrated enhanced fibroblast proliferation, reduced pro-inflammatory signaling, and increased collagen expression in cell cultures, and produced accelerated wound closure with improved tissue remodeling histology in animal wound models compared to controls [6]. These findings are preliminary and confined to preclinical models.

Researchers interested in related preclinical tissue repair research may also find the BPC-157 Research Overview relevant.

Angiogenesis Research

GHK-Cu’s interaction with angiogenic signaling has been investigated in cell culture models. A 2025 study developed novel conjugates of hyaluronic acid with GHK complexed to copper and found that the copper-containing formulations upregulated VEGF, BDNF, and BMP-2 expression — consistent with pro-angiogenic and pro-osteogenic signaling. The proposed mechanism involved copper chaperone proteins acting as transcription co-factors coordinating gene programs for vascular and bone-forming cells [7].

Anti-Inflammatory and Antioxidant Research

Several animal studies have examined GHK-Cu’s activity in inflammatory disease models. In a mouse model of bleomycin-induced pulmonary fibrosis, GHK-Cu treatment modulated MMP-9/TIMP-1 balance and partially blocked epithelial-to-mesenchymal transition through interactions with Nrf2, NF-κB, and TGF-β1 signaling pathways, reducing inflammatory cytokine levels and collagen deposition in lung tissue [8].

In a zebrafish larval inflammatory model, GHK-Cu decreased immune cell migration to challenge sites and suppressed pro-inflammatory cytokine expression following lipopolysaccharide challenge, with JAK1 pathway downregulation identified as a contributing mechanism [9]. A 2025 mouse model of chemically induced colitis found that GHK-Cu reduced disease activity scores and improved intestinal barrier integrity, with SIRT1 upregulation and phosphorylated STAT3 suppression identified through network pharmacology analysis and experimental validation [10].

On the antioxidant side, a 2024 mouse study demonstrated that GHK-Cu directly bound peroxiredoxin 6 (PRDX6), a key antioxidant enzyme, attenuating oxidative stress in alveolar macrophages and reducing lung inflammation and fibrosis in a silicosis model without significant systemic toxicity [11].

Neuroprotection and Metal Chelation Research

GHK has been investigated for neuroprotective properties in cell culture systems. A 2024 in vitro study demonstrated that GHK prevented copper- and zinc-induced protein aggregation and CNS cell death in cultured cells, including resolubilization of already-formed aggregates. The compound also attenuated paraquat toxicity — findings that raise GHK’s profile as a subject for research into neurodegenerative mechanisms involving metal ion dysregulation [12].

A 2017 bioinformatics analysis of GHK’s gene-expression profile in nervous system pathways identified modulation of genes associated with antioxidant defense, anti-inflammatory signaling, and neurotrophic activity — positioning GHK as a potential subject for aging neuroscience research, particularly in the context of its documented age-related plasma decline [13].

Aging Pathway Research

In the model organism Caenorhabditis elegans, GHK-Cu extended lifespan and improved age-related physical performance metrics through two coordinated mechanisms: preservation of mitochondrial integrity with enhanced ATP production, and activation of the DAF-16 and SKN-1 longevity-regulatory transcription factor pathways [14]. These findings are animal model results and cannot be extrapolated directly to human biology without dedicated clinical study.

Researchers interested in related compounds studied in mitochondrial function and cellular energy contexts may also find the SS-31 Research Overview and NAD+ Research Overview relevant.

Current Research Status and Regulatory Standing

Despite a substantial body of in vitro and animal model research, GHK-Cu has not been subjected to rigorous controlled clinical trials in humans. A 2024 review examining topical GHK applications noted a surprising absence of clinical trial evidence relative to the preclinical volume, and catalogued ongoing research into delivery enhancement strategies — including chemical lipidation, cell-penetrating peptide conjugation, and microneedle-assisted approaches — as active areas for bridging the gap between laboratory findings and clinical investigation [15].

GHK-Cu is not approved by the U.S. Food and Drug Administration or any comparable regulatory authority for human therapeutic use.

Research Use Note

GHK-Cu is supplied by New Tech Science exclusively for in vitro and preclinical laboratory research applications. This article is provided for educational purposes only and does not constitute medical advice. Researchers should consult current peer-reviewed literature and their institutional ethics framework before working with this compound.

References

1. Freedman JH, Pickart L, Weinstein B, Mims WB, Peisach J. Structure of the glycyl-L-histidyl-L-lysine–copper(II) complex in solution. Biochemistry. 1982;21(19):4540–4544. https://doi.org/10.1021/bi00262a004 (PMID 6291585)
2. Lau SJ, Sarkar B. The interaction of copper(II) and glycyl-L-histidyl-L-lysine, a growth-modulating tripeptide from plasma. Biochemical Journal. 1981;199(3):649–656. https://doi.org/10.1042/bj1990649 (PMID 7340824)
3. Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. 2015;2015:648108. https://doi.org/10.1155/2015/648108 (PMID 26236730)
4. Kang YA, Choi HR, Na JI, et al. Copper-GHK increases integrin expression and p63 positivity by keratinocytes. Archives of Dermatological Research. 2009;301(4):301–306. https://doi.org/10.1007/s00403-009-0942-x (PMID 19319546)
5. Choi HR, Kang YA, Ryoo SJ, et al. Stem cell recovering effect of copper-free GHK in skin. Journal of Peptide Science. 2012;18(11):685–690. https://doi.org/10.1002/psc.2455 (PMID 23019153)
6. Lee S, Lee SM, Lee SH, et al. In situ photo-crosslinkable hyaluronic acid-based hydrogel embedded with GHK peptide nanofibers for bioactive wound healing. Acta Biomaterialia. 2023;172:159–174. https://doi.org/10.1016/j.actbio.2023.10.011 (PMID 37832839)
7. Greco V, Lanza V, Tomasello B, et al. Copper Complexes with New Glycyl-l-histidyl-l-lysine-Hyaluronan Conjugates Show Antioxidant Properties and Osteogenic and Angiogenic Synergistic Effects. Bioconjugate Chemistry. 2025;36(4):662–675. https://doi.org/10.1021/acs.bioconjchem.4c00545 (PMID 40123442)
8. Ma WH, Li M, Ma HF, et al. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways. Life Sciences. 2020;241:117139. https://doi.org/10.1016/j.lfs.2019.117139 (PMID 31809714)
9. Hu J, Zhang C, Wang F. Glycyl-L-histidyl-L-lysine-Cu2+ (GHK-Cu) Attenuates CuSO4 or LPS induced-inflammation in Zebrafish larvae model. European Journal of Pharmacology. 2026;1023:178880. https://doi.org/10.1016/j.ejphar.2026.178880 (PMID 41997403)
10. Mao S, Huang J, Li J, et al. Exploring the beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms. Frontiers in Pharmacology. 2025;16:1551843. https://doi.org/10.3389/fphar.2025.1551843 (PMID 40672369)
11. Bian Y, Deng M, Liu J, et al. The glycyl-l-histidyl-l-lysine-Cu2+ tripeptide complex attenuates lung inflammation and fibrosis in silicosis by targeting peroxiredoxin 6. Redox Biology. 2024;75:103237. https://doi.org/10.1016/j.redox.2024.103237 (PMID 38879894)
12. Min JH, Sarlus H, Harris RA. Glycyl-l-histidyl-l-lysine prevents copper- and zinc-induced protein aggregation and central nervous system cell death in vitro. Metallomics. 2024;16(5):mfae019. https://doi.org/10.1093/mtomcs/mfae019 (PMID 38599632)
13. Pickart L, Vasquez-Soltero JM, Margolina A. The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline. Brain Sciences. 2017;7(2):20. https://doi.org/10.3390/brainsci7020020 (PMID 28212278)
14. Wen H, Zhao K, Luo X, et al. The GHK-Cu delays aging in Caenorhabditis elegans via coordinated regulation of mitochondrial function and activation of DAF-16/SKN-1 pathways. Biogerontology. 2026;27(3):100. https://doi.org/10.1007/s10522-026-10444-x (PMID 42084774)
15. Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR. Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective. BioImpacts. 2024;15:30071. https://doi.org/10.34172/bi.30071 (PMID 39963574)